William Blair & Company
LYRA

William Blair & Company’s LYRA THERAPEUTICS INC LYRA Stock Holding History

William Blair & Company’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,100
Closed -$442K – 1915
2021
Q2 		$442K Hold
1,100
– – ﹤0.01% 1193
2021
Q1 		$637K Buy
+1,100
New +$687K ﹤0.01% 1048

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

William Blair & Company's LYRA Position: Q3 2021 in Review

William Blair & Company sold out of LYRA THERAPEUTICS INC (LYRA) in Q3 2021, closing a stake of 1,100 shares — an estimated $442K sold.

William Blair & Company first reported a position in LYRA in Q1 2021 and held it in 2 quarters. The position peaked at $637K in Q1 2021. 35 funds tracked by Wall St. Rank hold LYRA as of Q3 2021.

  • William Blair & Company reported no remaining LYRA THERAPEUTICS INC position as of Q3 2021 after selling out during the quarter.
  • William Blair & Company sold 1,100 LYRA THERAPEUTICS INC shares in Q3 2021, an estimated $442K.
  • William Blair & Company first reported a position in LYRA THERAPEUTICS INC in Q1 2021 and held it in 2 quarters.
  • William Blair & Company's LYRA THERAPEUTICS INC position peaked at $637K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q3 2021.

Based on William Blair & Company's 13F filing for Q3 2021, filed 12 Nov 2021.